Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
KAICO Logo
KAICO Growth Score
91
CB Rank
43992
Heat Score
76
KAICO is a biotechnology company that provides hard-expressing proteins to develop drugs with a silkworm-baculovirus expression system.
Founded
obfuscation
PrivateSeries B Nishiku, Fukuoka, Japan11-50 www.kaicoltd.jp
Alternative Medicine
Biotechnology
Pharmaceutical
Product Research
Overview

KAICO
Total Funding
obfuscation
Growth Score
91
Heat Score
76

Total Funding
obfuscation
obfuscation
Series B raised
obfuscation
Growth Score91
-3 pts
in past quarter
Heat Score 76
7 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+3 more milestones
See more interactive data and historical milestones on desktop for the best experience

About KAICO

CB Rank
43992
KAICO is a biotechnology company that provides hard-expressing proteins to develop drugs with a silkworm-baculovirus expression system.
Founded
obfuscation
PrivateSeries B Nishiku, Fukuoka, Japan11-50 www.kaicoltd.jp
Alternative Medicine
Biotechnology
Pharmaceutical
Product Research

Funding Rounds

Series B
OBF
in
obfuscation
Series A
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Key People

Details

Legal Name KAICO Ltd.
Operating Status Active
Company Type For Profit
Founders  Kenta Yamato
About the Company
KAICO is a pharmaceuticals, diagnostic drugs production company.
Phone Number +81 92-707-4016
Contact Email info-kaico@kaicoltd.jp
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

Silkworm-Baculovirus Expression System
A protein production platform using silkworms infected with a proprietary baculovirus to express target recombinant proteins.
Protein Expression Service
A contract service for trial expression and production of customized recombinant proteins using the silkworm-baculovirus system.

Research & Development

KAICO is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - KAICO Logo
Series B - KAICO
7
obfuscation
— Series B
obfuscation
Series B - KAICO Logo
Series B - KAICO
7
obfuscation
— Series B
obfuscation
Series B - KAICO Logo
Series B - KAICO
7
obfuscation
— Series B
obfuscation
Series B - KAICO Logo
Series B - KAICO
7
obfuscation
— Series B
obfuscation
Series B - KAICO Logo
Series B - KAICO
7
obfuscation
— Series B

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - KAICO Logo
Series B - KAICO
7
obfuscation
— Series B
obfuscation
Series B - KAICO Logo
Series B - KAICO
7
obfuscation
— Series B
obfuscation
Series B - KAICO Logo
Series B - KAICO
7
obfuscation
— Series B
obfuscation
Series B - KAICO Logo
Series B - KAICO
7
obfuscation
— Series B
obfuscation
Series B - KAICO Logo
Series B - KAICO
7
obfuscation
— Series B

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1

Employee Profiles

News

News and Press

News•Jun 4, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 25, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 7, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 2, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

607
104.38%
 in past month

Active Website Tech Count

5KAICO is actively using 5 technologies for its website, according to BuiltWith. These include WordPress 6.9, Common Name Invalid, and  CommonCrawl Top 1m.

Total IP

6The intellectual property of KAICO includes 3 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, KAICO has registered 3 trademarks with the most popular class being 'Bleaching, cleaning, polishing, scouring and abrasive preparations; cosmetics', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is KAICO's headquarters? KAICO is located in Nishiku, Fukuoka, Japan.Who invested in KAICO? KAICO has 13 investors including ITOCHU Technology Ventures and  Sagin Capital & Consulting.When was the last funding round for KAICO? KAICO closed its last funding round on
obfuscation
from a Series B round.Who are KAICO's competitors? Alternatives and possible competitors to KAICO may include Thermo Fisher Scientific, VectorBuilder, and  Charles River Laboratories International.How much funding has KAICO raised to date? KAICO has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3237dbc 1)
|